3
Views
36
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

TATA Binding Protein Discriminates between Different Lesions on DNA, Resulting in a Transcription Decrease

, , , &
Pages 3907-3914 | Received 08 Jan 1998, Accepted 24 Apr 1998, Published online: 28 Mar 2023

REFERENCES

  • Adamczewski, J. A., M. Rossignol, J. P. Tassan, E. A. Nigg, V. Moncollin, and J. M. Egly 1996. MAT1, cdk7 and cyclin H form a kinase complex which is UV light sensitive upon association with TFIIH. EMBO J. 15: 1877–1884.
  • Alazard, R. J., and M. Germanier 1982. Post replication repair in an excision defective strain of Escherichia coli following treatment with cis dichlorodiammineplatinum(II). Biochem. Biophys. Res. Commun. 104: 693–700.
  • Bellon, S. F., and S. J. Lippard 1990. Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+. Biophys. Chem. 35: 179–188.
  • Bohr, V. A., C. A. Smith, D. S. Okumoto, and P. C. Hanawalt 1985. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40: 359–369.
  • Boulikas, T. 1996. DNA lesion-recognizing proteins and the p53 connection. Anticancer Res. 16: 225–242.
  • Bregman, D., et al. Personal communication.
  • Buratowski, S., S. Hahn, L. Guarente, and P. A. Sharp 1989. Five intermediate complexes in transcription initiation by RNA polymerase II. Cell 56: 549–561.
  • Davison, B. L., J. M. Egly, E. R. Mulvihill, and P. Chambon 1983. Formation of stable preinitiation complexes between eukaryotic class B transcription factors and promoter sequences. Nature 301: 680–686.
  • Dubin, R. A., and H. Ostrer 1994. Sry is a transcriptional activator. Mol. Endocrinol. 8: 1182–1192.
  • Eastman, A. 1986. Reevaluation of interaction of cis-dichloro(ethylenediamine) platinum(II) with DNA. Biochemistry 25: 3912–3915.
  • Fichtinger-Schepman, A. M., A. T. van Oosterom, P. H. Lohman, and F. Berends 1987. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 47: 3000–3004.
  • Fire, A., M. Samuels, and P. A. Sharp 1984. Interactions between RNA polymerase II, factors, and template leading to accurate transcription. J. Biol. Chem. 259: 2509–2516.
  • Gérard, M., L. Fischer, V. Moncollin, J.-M. Chipoulet, P. Chambon, and J.-M. Egly 1991. Purification and interaction properties of the human RNA polymerase B(II) general transcription factor BTF2. J. Biol. Chem. 266: 20940–20945.
  • Hansson, J., and R. D. Wood 1989. Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II). Nucleic Acids Res. 17: 8073–8091.
  • Hardwick, J. M., R. S. von Sprecken, K. L. Yielding, and L. W. Yielding 1984. Ethidium binding sites on plasmid DNA determined by photoaffinity labeling. J. Biol. Chem. 259: 11090–11097.
  • Harley, V. R., D. I. Jackson, P. J. Hextall, and J. R. Hawkins 1992. DNA binding activity of recombinant SRY from normal males and XY females. Science 255: 453–456.
  • Herlich, P. Personal communication.
  • Hoeijmakers, J. H. J., J. M. Egly, and W. Vermeulen 1996. TFIIH: a key component in multiple DNA transactions. Curr. Opin. Genet. Dev. 6: 26–33.
  • Jennerwein, M. M., A. Eastman, and A. R. Khokhar 1991. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation. Mutat. Res. 254: 89–96.
  • Jones, C. J., and R. D. Wood 1993. Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32: 12096–12104.
  • Kim, J. L., D. B. Nikolov, and S. W. Burley 1993. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365: 520–527.
  • Kim, Y., J. H. Geiger, S. Hahn, and P. B. Sigler 1993. Crystal structure of a yeast TBP/TATA-box complex. Nature 365: 512–520.
  • Kozelka, J., S. Archer, G. A. Petsko, S. J. Lippard, and G. J. Quigley 1987. Molecular mechanics modeling of oligonucleotide adducts of the antitumor drug cis-diamminedichloroplatinum(II). Biopolymers 26: 1245–1271.
  • Kraker, A. J., and C. W. Moore 1988. Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res. 48: 9–13.
  • Lemaire, M. A., A. Schwartz, A. R. Rahmouni, and M. Leng 1991. Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc. Natl. Acad. Sci. USA 88: 1982–1985.
  • Lepre, C. A., and S. J. Lippard 1990. Interactions of platinum antitumor compounds with DNA. Nucleic Acids Mol. Biol. 4: 9–38.
  • Li, R. Y., P. Calsou, C. J. Jones, and B. Salles. Interaction of the transcription/DNA repair factor TFIIH and XPA repair protein with DNA lesions in a cell-free repair assay. Submitted for publication.
  • Lu, H., L. Zawel, L. Fischer, J. M. Egly, and D. Reinberg 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358: 641–645.
  • Malinge, J. M., C. Perez, and M. Leng 1994. Base sequence-independent distortions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA. Nucleic Acids Res. 22: 3834–3839.
  • Mellon, I., G. Spivak, and P. C. Hanawalt 1987. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51: 241–249.
  • Milhé, C., R. P. P. Fuchs, and J. F. Lefèvre 1996. NMR data show that the carcinogen N-2-acetylaminofluorene stabilises an intermediate of −2 frameshift mutagenesis in a region of high mutation frequency. Eur. J. Biochem. 235: 120–127.
  • Moggs, J. C., K. J. Yarema, J. M. Essigmann, and R. D. Wood 1996. Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct. J. Biol. Chem. 271: 7177–7186.
  • Nocentini, S., F. Coin, M. Saijo, K. Tanaka, and J. M. Egly 1997. DNA damage recognition by XPA protein promotes efficient recruitment of transcription factor IIH. J. Biol. Chem. 272: 22991–22994.
  • Park, C. H., D. Mu, J. T. Reardon, and A. Sancar 1995. The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J. Biol. Chem. 270: 4896–4902.
  • Pil, P. M., and S. J. Lippard 1992. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256: 234–237.
  • Plooy, A. C., A. M. Fichtinger-Schepman, H. H. Schutte, M. van Dijk, and P. H. Lohman 1985. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. Carcinogenesis 6: 561–566.
  • Salles, B., C. Provot, P. Calsou, I. Hennebelle, I. Gosset, and G. J. Fournie 1995. A chemiluminescent microplate assay to detect DNA damage induced by genotoxic treatments. Anal. Biochem. 232: 37–42.
  • Svejstrup, J. C., P. Vichi, and J. M. Egly 1996. The multiple roles of transcription/repair factor TFIIH. Trends Biochem. Sci. 21: 346–350.
  • Takahara, P. M., A. C. Rosenzweig, C. A. Frederick, and S. J. Lippard 1995. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377: 649–652.
  • Tudek, B., S. Boiteux, and J. Laval 1992. Biological properties of imidazole ring-opened N7-methylguanine in M13mp18 phage DNA. Nucleic Acids Res. 20: 3079–3084.
  • Van Vuuren, A. J., W. Vermeulen, L. Ma, G. Weeda, E. Appeldorn, N. G. J. Jaspers, A. J. van der Eb, J. H. J. Hoeijmakers, S. Humbert, L. Shaeffer, and J. M. Egly 1994. Correction of Xeroderma repair defect by basal transcription factor BTF2/TFIIH. EMBO J. 13: 1645–1653.
  • Vassylyev, D. G., T. Kashiwagi, Y. Mikami, M. Ariyoshi, S. Iwai, E. Ohtsuka, and K. Morikawa 1995. Atomic model of a pyrimidine dimer excision repair enzyme complexed with a DNA substrate: structural basis for damaged DNA recognition. Cell 83: 773–782.
  • Vichi, P., F. Coin, J. P. Renaud, W. Vermeulen, J. H. J. Hoeijmakers, D. Moras, and J. M. Egly 1997. Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J. 16: 7444–7456.
  • Werner, M. H., J. R. Huth, A. M. Gronenborn, and G. M. Clore 1995. Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81: 705–714.
  • Yang, D., S. G. E. Van Boom, J. Reedijk, J. H. Van Boom, and A. H. J. Wang 1995. Structure and isomerization of an intrastrand cisplatin-cross linked octamer DNA duplex by NMR analysis. Biochemistry 34: 12912–12920.
  • Zamble, D. B., D. Mu, J. T. Reardon, A. Sancar, and S. J. Lippard 1996. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35: 10004–10013.
  • Zawel, L., K. P. Kumar, and D. Reinberg 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev. 9: 1479–1490.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.